Related Experiment Video
Updated: Aug 19, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Heart failure: a growing public health problem
1University of Göteborg, Department of Medicine, Ostra Hospital, Sweden.
Insights
Heart failure is a growing public health concern, with increasing mortality despite declining deaths from heart disease. Early recognition and treatment, including ACE inhibitors, show promise for improving patient outcomes and reducing healthcare costs.
Area of Science:
- Cardiology
- Public Health
- Geriatrics
Background:
- Heart failure (HF) mortality is rising, contrasting with declining coronary heart disease and stroke deaths.
- HF is a significant financial burden, with approximately one-third of patients hospitalized annually.
- HF prevalence and incidence increase sharply with age, affecting nearly 10% of individuals over 80.
Purpose of the Study:
- To review the scope of heart failure as an escalating public health issue.
- To examine the causes, risk factors, and current treatment strategies for heart failure.
- To highlight the potential benefits of early intervention and preventative measures.
Main Methods:
- Literature review of large-scale studies on heart failure prevalence, incidence, and treatment.
- Analysis of the impact of ACE inhibitors on heart failure outcomes.
- Examination of public health and economic implications of heart failure management.
Main Results:
- Angiotensin-converting enzyme (ACE) inhibitors have demonstrated efficacy in reducing heart failure mortality, preventing disease development, and decreasing hospitalizations.
- Effective management strategies can lead to significant economic benefits for public health systems.
- Preventing underlying causes and risk factors for heart failure offers the most substantial long-term benefits.
Conclusions:
- Heart failure represents a growing public health challenge requiring urgent attention.
- Early recognition and timely, adequate treatment, particularly with ACE inhibitors, are crucial for improving prognosis and reducing healthcare burdens.
- Preventative strategies targeting underlying causes and risk factors are paramount for long-term population health and economic well-being.
Abstract:
At a time when deaths from coronary heart disease and stroke are markedly declining, mortality from heart failure is increasing. Heart failure is a costly and devastating disease, and throughout much of the industrialized world, escalating health-care costs constitute a serious burden on both public and private systems of financing health care, and about one-third of all heart failure patients are admitted to hospital each year. Both prevalance and incidence of heart failure increase steeply with increasing age. The prevalence rate is about 1% at the age of 50, whilst at the age of 80 and above, almost one out of 10 persons will suffer from heart failure. Until recently, the goals for heart failure treatment were to relieve symptoms and enhance functional capacity. Recently, some large scale studies have shown that ACE inhibitors can reduce mortality, prevent development of heart failure, avoid the need for hospitalization and improve prognosis. ACE inhibitors may therefore have promising effects both on patients and on society. A challenge for the future must be early recognition and timely and adequate treatment of heart failure. Such a strategy might have great economic benefits as far as public health is concerned. However, the most rewarding efforts for the population will be to prevent the underlying causes of coronary heart failure as well as risk factors for heart failure. This review will study the magnitude of heart failure as a growing public health problem, the underlying causes, risk factors and treatment.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions

